In our study, we found that the level of S100A9 and the heterocomplex S100A8/A9 are significantly unregulated in the sera of NASH patients with more prominent increase in the sera of NASH patients with fibrosis. The gene discussed is IGKV1D-22; the disease is metabolic dysfunction-associated steatohepatitis.